This is an interdisciplinary post-doctoral training grant application for 6 positions per year. The area of training is in hypertension, arteriosclerosis and vascular biology. The research training period is for two more years. The trainees are trained for positions in academic medicine. Additional clinical training for board qualification is supported by hospital sources. The departments include Internal Medicine Cardiology, Endocrinology and Nephrology), Pediatrics (Nephrology Cardiology), Anesthesiology, Biochemistry, Physiology Pharmacology and Biomedical Engineering. This is the only NIH institutional training grant supporting M.D. cardiovascular research training in the clinical departments of this institution. Almost all of the trainees have a basic scientist as a mentor; some have more than one mentor. The main research training projects have been in molecular or cell biology, however, and projects in whole animals and human subjects are done. There are three strong research areas that support the major part of research training: vascular smooth muscle program project group, the group working on the renin-angiotensin-aldosterone system and the vascular biology/arteriosclerosis program group. The greatest strength of this training program is the recruitment of highly qualified MD trainees to this program. We are now averaging 6 MD trainees/year. These trainees elect basic training that my include both a basic and clinical science mentors. Basic statistics, data management and research ethics are the only required courses but those training in vascular biology are required to take Vascular Cell Biology and Cellular and Molecular Biology are strongly recommended. The trainees are expected to attend lab meetings, selected seminars in Physiology, Vascular Smooth Muscle, Vascular Biology, Pharmacology, Biochemistry and Internal Medicine. Monthly journal clubs and research seminars in Cardiology are attended. MD trainees may earn the PhD degree. The research environment is superior and research grant support of the faculty is excellent.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Institutional National Research Service Award (T32)
Project #
5T32HL007355-24
Application #
6490341
Study Section
Special Emphasis Panel (ZHL1-CSR-K (F1))
Program Officer
Schucker, Beth
Project Start
1994-07-01
Project End
2004-06-30
Budget Start
2002-07-01
Budget End
2003-06-30
Support Year
24
Fiscal Year
2002
Total Cost
$214,531
Indirect Cost
Name
University of Virginia
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
001910777
City
Charlottesville
State
VA
Country
United States
Zip Code
22904
Redwine, Laura S; Henry, Brook L; Pung, Meredith A et al. (2016) Pilot Randomized Study of a Gratitude Journaling Intervention on Heart Rate Variability and Inflammatory Biomarkers in Patients With Stage B Heart Failure. Psychosom Med 78:667-76
Manichaikul, Ani; Rich, Stephen S; Perry, Heather et al. (2014) A functionally significant polymorphism in ID3 is associated with human coronary pathology. PLoS One 9:e90222
Lipinski, Michael J; Campbell, Kirsti A; Duong, Son Q et al. (2012) Loss of Id3 increases VCAM-1 expression, macrophage accumulation, and atherogenesis in Ldlr-/- mice. Arterioscler Thromb Vasc Biol 32:2855-61
Mirza, M Ayoub; Lane, Susan; Yang, Zequan et al. (2012) Phospholemman deficiency in postinfarct hearts: enhanced contractility but increased mortality. Clin Transl Sci 5:235-42
Cutchins, Alexis; Harmon, Daniel B; Kirby, Jennifer L et al. (2012) Inhibitor of differentiation-3 mediates high fat diet-induced visceral fat expansion. Arterioscler Thromb Vasc Biol 32:317-24
Doran, Amanda C; Lipinski, Michael J; Oldham, Stephanie N et al. (2012) B-cell aortic homing and atheroprotection depend on Id3. Circ Res 110:e1-12
Campbell, Kirsti A; Lipinski, Michael J; Doran, Amanda C et al. (2012) Lymphocytes and the adventitial immune response in atherosclerosis. Circ Res 110:889-900
Deliri, Hamid; Meller, Nahum; Kadakkal, Ajay et al. (2011) Increased 12/15-lipoxygenase enhances cell growth, fibronectin deposition, and neointimal formation in response to carotid injury. Arterioscler Thromb Vasc Biol 31:110-6
Doran, Amanda C; Lehtinen, Allison B; Meller, Nahum et al. (2010) Id3 is a novel atheroprotective factor containing a functionally significant single-nucleotide polymorphism associated with intima-media thickness in humans. Circ Res 106:1303-11
Yeboah, Joseph; McNamara, Coleen; Jiang, Xian-Cheng et al. (2010) Association of plasma sphingomyelin levels and incident coronary heart disease events in an adult population: Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol 30:628-33

Showing the most recent 10 out of 60 publications